8 mg Aflibercept in Diabetic Macular Edema

Subretinal Gene Therapy for Neovascular AMD

Does Pegcetacoplan Treatment Affect Dry Macular Degeneration?

Rapid Fluid Resolution with Aflibercept 8mg may be Associated with Extended Dosing Intervals in nAMD

The Good Days Dilemma - Support for Patient Co-Payments in Retinal Pharmacotherapy

Immediate vs Delayed Treatment of GA with Pegcetacoplan

Eyes with both Geographic Atrophy and Neovascular AMD: An IRIS Study

The Davio 2 Trial for Neovascular AMD

The GALE Extension Study

AXPAXLI for Diabetic Retinopathy

NSAIDS in the treatment of Central Serous Chorioretinopathy

EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

Intravitreal Gene Therapy for neovascular AMD with 4D-150

KSI 501 Bispecific Anti-VEGF Biopolymer Treatment of DME

Retinal Vasculitis Following Pegcetcoplan Therapy of Geographic Atrophy

High Dose Aflibercept in Severe Diabetic Macular Edema

IL-6 Inhibition in the Treatment of Uveitis Macular Edema

The High Dose Aflibercept DME Trial

The Annexon Geographic Atrophy Trial

Diagnostics for Retinoblastoma